GSK, Singapore BTI Collaborate On Vaccine Development
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Singapore's Bioprocessing Technology Institute and GlaxoSmithKline Biologicals SA Belgium reached an agreement in late January to collaborate on three vaccine and adjuvant-related research projects